EBE. V. Balakin

E. V. Balakin

*This is an algorithmically generated author record based on publicly available information.

E. V. Balakin has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Severe aortic stenosis in surgery of acquired heart disease: long-term results

    by V.A. Ivanov, E.P. Evseev, E.V. Ivanova, L.N. Ivanova, T.G. Nikityuk, M.A. Fomin, Ya.A. Aydamirov, E.V. Balakin

    Objective. To evaluate long-term survival, physical activity, hemodynamic parameters on aortic prosthesis and cardiac remodeling after surgical treatment of severe aortic stenosis. Material and methods. In 2019, we retrospectively analyzed the results of 100 consecutive surgeries in patients with critical aortic stenosis. Appropriate surgical intervention, anesthesia, perfusion and intensive care reduced in-hospital mortality and morbidity in these patients. Ninety-eight patients were discharged. Results. The follow-up period was 7.8 (range 6.3—10.0) years. In long-term period, 6 patients died, and 10-year Kaplan-Meier survival rate was 94%. There were no redo surgeries. Dysfunction of aortic prosthesis was observed in one patient due to pannus. Twenty-five (29%) patients were assigned to functional class I, 59 (69%) — class II, and only 2 (2%) patients were assigned to class III. According to transthoracic echocardiography, maximum and mean pressure gradients were 30.5±14.1 and 16.6±9.6 mm Hg, respectively. Regression of myocardial mass and myocardial mass index was 22% and 23% compared to early postoperative data, respectively. Conclusion. In patients with severe aortic stenosis and extremely unfavorable clinical prognosis, surgical treatment remains the main method. Normalization of intracardiac hemodynamics leads to significant reverse cardiac remodeling and improves QoL and life expectancy.

  • Triple valve replacement after recurrent infective endocarditis and previous COVID-19 infection

    by D.A. Podchasov, V.A. Ivanov, E.P. Evseev, Ya.A. Aidamirov, E.V. Ivanova, E.V. Balakin, A.A. Botashev

    The authors present redo mitral valve replacement, aortic valve and tricuspid valve replacement in a patient with recurrent infective endocarditis following COVID-19 infection. This patient with EuroSCORE II 19.24% underwent successful triple valve replacement.

  • Long-term results of multivalvular correction of heart defects

    by V.A. Ivanov, E.P. Evseev, E.V. Ivanova, L.N. Ivanova, T.G. Nikityuk, Ya.A. Aidamirov, E.V. Balakin, M.A. Nechaenko, M.A. Fomin, S.B. Mikhlin, et al.

    Objective. To evaluate the long-term results of surgical correction of multivalvular heart defects. Material and methods. In the department of heart defects surgery, 51 patients underwent replacement of two or more heart valves between 2023 and 2025. In the long-term period, which averaged 19.5±6.3 (9±29) months, 47 patients were examined. Survival was evaluated at the primary endpoint. Functional state by the NYHA, lack of thromboembolic and hemorrhagic complications, heart remodeling and intracardiac hemodynamics according to the echocardiography data, as well as metabolic, cardiovascular indices, parameters of lung ventilation and pulmonary gas exchange according to the data of ergospirometry were assessed at the secondary endpoint. Results. The long-term actuarial survival amounted to 92.5%. Massive gastric hemorrhage due to an anticoagulant overdose was the cause of one fatal case. A clinically significant health improvement has been noted in the majority of patients; functional class I (FC) by the NYHA has been noted in 17 patients (37.5%), FC II by the NYHA — in 25 (54%), FC III by the NYHA — in 4 (8.5%). The absence of hemorrhagic complications by Kaplan-Meyer amounted to 95%, there were no episodes of thromboembolism. According to the ergospirometry, mean values of exercise tolerance and peak oxygen consumption reached 102.1±22.5 W and 15.6±3.4 ml/kg/min, respectively. Conclusion. Surgical correction of multivalvular heart defects allows to significantly improve the intracardiac hemodynamics, survival and functional status in the long-term period as the only effective treatment method for patients in this particularly complex category.

  • Surgery for heart valve disease and cardiac tumors via mini-thoracotomy: experience of 300 interventions

    by E.P. Evseev, E.V. Balakin, I.A. Aidamirov, M.A. Fomin, A.A. Botashev, N.N. Tolmacheva, T.G. Nikityuk, Yu.V. Belov

    Objective. To evaluate the effectiveness and safety of surgery for heart valve disease and cardiac tumors via right-sided anterior minithoracotomy. Material and methods. A retrospective analysis included 309 patients with heart valve disease, atrial septal defects and cardiac tumors. All patients underwent correction of defect or removal of neoplasm via right-sided minithoracotomy. Results. In early postoperative period, there was 1 (0.3%) dearth due to left ventricular rupture. Mean surgery time was 191 min [171; 218], cardiopulmonary bypass time — 91 min [77; 110], aortic cross-clamping time — 69 min [63; 82], intraoperative blood loss — 450 ml [400; 500]. Conversion to sternotomy was performed in 7 (2.3%) cases. Mechanical ventilation time was 4.5 hours [3; 6], ICU-stay — 1 day, postoperative hospital-stay — 7 days [6; 8]. Conclusion. Correction of valvular and structural defects, as well as cardiac tumor removal via minithoracotomy is reproducible and effective. These procedures are associated with low mortality, good cosmetic outcomes and preservation of chest wall function. Correction of mitral valve disease through min-thoracotomy in early phase of technique development was associated with prolonged surgery, cardiopulmonary bypass and aortic cross-clamping.

  • Left atrial reduction in mitral valve surgery

    by D.A. Podchasov, E.P. Evseev, Ya.A. Aidamirov, A.V. Stonogin, E.V. Balakin, T.G. Nikityuk, Yu.V. Belov

    Objective. To evaluate the immediate results of left atrial reduction in correction of mitral valve disease complicated by left atrial enlargement. Material and methods. A retrospective analysis of surgical treatment included 100 patients (48 men and 52 women, mean age 69.9±11.1) who underwent left atrial reduction (main group) between 2013 and 2023. Preoperative left atrial volume was 334±235 ml (200—1430). For detailed analysis, the main group was divided into two subgroups: baseline left atrium volume 300 ml (36 (36%) patients). The control group included 44 patients (23 men and 21 women, mean age 60.2±10.3 years), who underwent mitral valve surgery without left atrial reduction. Preoperative left atrial volume in the control group was 248 ml (200—550). Results. In-hospital mortality in the main group was 2%. Postoperative left atrium volume in the main group was 111±76.3 ml. Upon discharge, sinus rhythm was recorded in 61 patients (62%). In 11 patients, baseline sinus rhythm was stable after surgery. In 50 (51%) patients, sinus rhythm was restored. Among 55 patients after additional radiofrequency Cox Maze IV procedure, stable sinus rhythm was observed in 43 (78%) cases. There were no deaths in the control group. Left atrium volume decreased from 248 (220—315) to 200 (180—240) ml. Sinus rhythm was maintained or restored in 7 (16%) patients. When analyzing the correlation of sinus rhythm recovery after surgery with baseline left atrium volume and duration of atrial fibrillation, we found that the most frequent restoration of sinus rhythm was observed in patients with baseline left atrium volume <400 ml and duration of atrial fibrillation <20 months. Conclusion. Left atrial reduction improves postoperative outcomes in this complex group of patients. Correction of heart valve disease and left atrial reduction are effective to restore sinus rhythm.

  • Open Access

    Choice of an artificial lung ventilation technique for the correction of mitral valve pathology from a mini-thoracotomy approach

    by N. N. Tolmacheva, T. A. Pshenichnyy, N. V. Menshikh, A. V. Goncharova, E. P. Evseev, E. V. Balakin, Ya. A. Aidamirov, Б. А. Аксельрод

    Background. In recent years, there has been a growing number of cardiac surgeries performed using minimally invasive techniques. However, there is still debate about the optimal ventilation support for these operations, which are performed through a mini-thoracotomy.The objective was to study the possibility of using high-frequency jet ventilation during minimally invasive mitral valve surgery performed from right-sided mini-thoracotomy, to evaluate its effectiveness and safety.Materials and methods. 80 patients were divided into two groups: one group received high-frequency jet ventilation (HFJV), and the other received low-volume ventilation (LVV). Before surgery, during surgery, and in the intensive care unit, invasive hemodynamic parameters, arterial blood gas composition, and metabolic markers were assessed. The nature and incidence of postoperative complications were also analyzed.Results. In the HFJV group, compared to the LVV group, the level of oxygen tension in arterial blood (PaO2) was significantly higher at 30 minutes after thoracotomy – 307 (220–352) mmHg versus 106 (90–127.5) mmHg, p < 0.001, and at 30 minutes after the end of cardiopulmonary bypass (CPB) – 264 (188–323) mmHg versus 147 (109.5–183.5) mmHg, p < 0.001. PaO2/FiO2 was also higher in the HFJV group compared to the LVV group at these stages – 623 (450–714) versus 214 (171.3–263.3), p < 0.001 and 534 (367–654) versus 260 (200.5 – 358), p < 0.001. The number of patients with a PaO2/FiO2 of 200 or lower in the HFJV group was significantly lower than in the LVV group – 2.5 % compared to 32 %, p < 0,001 before CPB and 5 % compared to 25 %, р = 0,013 after CPB.There was no statistically significant difference between the groups in the number of postoperative pulmonary complications, as well as the duration of artificial lung ventilation (ALV) and stay in the intensive care unit (ICU).Conclusions. The use of high-frequency jet ventilation during minimally invasive mitral valve surgery performed through right-sided mini-thoracotomy provides adequate oxygenation and prevents the development of hypoxemia. This technique does not increase the number of postoperative complications.

  • Immediate results of mitral and aortic valve replacement with simultaneous Cox-Maze IV procedure

    by E.P. Evseev, A.A. Botashev, I.A. Aidamirov, E.V. Balakin, M.A. Fomin, V.A. Ivanov, Yu.V. Belov

    Objective. To evaluate the immediate outcomes of mitral and aortic valve replacement with simultaneous Cox-Maze IV procedure. Material and methods. A retrospective study included 23 patients who underwent mitral and aortic valve replacement with simultaneous Cox-Maze IV procedure between 2017 and 2023. Results. Sinus rhythm at discharge was noted in 17 (81%) patients, atrial fibrillation — in 4 (19%) patients. Postoperative hospital-stay was 9 (7; 10) days. Among patients with paroxysmal AF, sinus rhythm at discharge was restored in 5 (83.3%) out of 6 patients, in persistent AF — 3 (100%) out of 3 patients, in longstanding persistent AF — 9 (75%) out of 12 patients. No cases of permanent pacemaker implantation were observed. Conclusion. Mitral and aortic valve replacement with simultaneous Cox-Maze IV procedure is effective and safe. This approach improves early and long-term outcomes, as well as quality of life.

  • Open Access

    A case of successful treatment of mitral insufficiency from mini-thoracotomy in a patient with severe thoracic deformity

    by E.P. Evseev, A.M. Dzharu, Ya.A. Aydamirov, E.V. Balakin, N.N. Tolmacheva, M.A. Fomin, M.V. Malahova, V.V. Khovrin

    Успешное лечение митральной недостаточности из мини-торакотомии у пациентки с выраженной деформацией грудной клетки

  • Immediate outcomes of simultaneous Cox-Maze procedure in patients with isolated and multivalvular heart defects via right mini-thoracotomy

    by E.P. Evseev, E.V. Balakin, I.A. Aidamirov, M.A. Fomin, A.A. Botashev, S.V. Fedulova, M.V. Malakhova, N.B. Korchazhkina, K.V. Kotenko, S.O. Popov

    Objective. To evaluate the immediate outcomes and safety of simultaneous Maze procedure in patients with isolated and multivalvular heart disease via right-sided mini-thoracotomy. Material and methods. A retrospective analysis of postoperative outcomes included 21 patients with various valvular heart diseases and atrial septal defects with atrial fibrillation. All patients underwent heart valve surgery with cryoablation (left atrial, right atrial or biatrial «Maze» approach) via right-sided mini-thoracotomy. Results. There were no unfavorable outcomes. Mean surgery time was 214 min (193; 241), cardiopulmonary bypass time — 116 min (96; 133), aortic cross-clamping time — 90 min (76; 97). Intraoperative blood loss was approximately 500 mL (400; 600). Conversion to sternotomy was required in 1 case (4.8%). In most case (90.5%), length of ICU-stay was 1 day, hospital-stay — 7 days (7; 10). Twenty patients (95.2%) had sinus rhythm at discharge. Conclusion. Simultaneous heart valve surgery and Maze procedure are effective and reproducible. This approach is associated with low mortality, preservation of thoracic wall stability, favorable cosmetic results and stable sinus rhythm in 95.4% of patients. Left atrial and biatrial variants of this procedure can be successfully performed depending on the type of atrial fibrillation and specific valve disease.


  • Immediate and long-term results of the simultaneous rhythm-converting procedure Cox-Maze IV in multivalvular correction

    by E.P. Evseev, A.A. Botashev, I.A. Aidamirov, E.V. Balakin, M.A. Fomin, A.O. Fazylov, V.A. Ivanov, Yu.V. Belov

    Objective. This study aimed to investigate the immediate and long-term outcomes of the Cox-Maze IV procedure in patients undergoing surgical treatment for multivalvular heart disease with atrial fibrillation. It also sought to identify predictors of atrial fibrillation recurrence in the long-term period. Materials and methods. We conducted an analysis of 92 patients who underwent multivalvular heart defect correction and simultaneous Cox-Maze IV procedure between 2017 and 2023. The mean age of the patients was 65.5 years (57.5; 69), 43 males (46.7%) and 49 females (53.3%). Sixty-six patients (71.7%) were classified as functional class III heart failure according to NYHA, while 3 (3.3%), 14 (15.2%), and 9 (9.8%) were classified as functional classes I, II, and IV, respectively. The types of atrial fibrillation were: paroxysmal in 15.2%, persistent in 22.8%, and long-standing persistent in 62%. The mean duration of atrial fibrillation prior to surgery was 15.5 months (10; 45.8) for those with paroxysmal form, 7 months (4; 9) for persistent form, and 60 months (22; 84) for long-standing persistent form. Mitral-aortic valve replacement was performed in 9 cases (9.8%), mitral-tricuspid correction in 69 cases (75%), and combined mitral-aortic-tricuspid correction in 14 cases (15.2%). Results. During the hospital stay, there were 3 fatalities. In the long-term follow-up, 8 deaths were recorded, with 3 attributed to cardiac causes. Permanent pacemaker implantation was required in just one case during the long-term postoperative period. The freedom from atrial fibrillation was 61.4% in patients with paroxysmal form at follow-up of up to 46 months, 58.1% in those with persistent form at up to 63 months, and 32.5% in those with long-standing persistent form at up to 82 months. Three predictors of arrhythmia recurrence were identified: early postoperative atrial fibrillation paroxysms, a duration of atrial fibrillation exceeding 60 months, and enlarged left atrial size. Conclusions. The Cox-Maze IV rhythm-conversion procedure designed to restore sustained sinus rhythm is most effective in patients with paroxysmal and persistent forms of atrial fibrillation, achieving success rates of 61.4% and 58.1%, respectively. This procedure is not associated with a high rate of pacemaker implantation. An enlarged left atrium should not deter the use of the Cox-Maze IV procedure in patients with atrial fibrillation; however, atrioplasty is recommended if the left atrium is significantly enlarged. Episodes of rhythm disturbance during the early postoperative period and a history of atrial fibrillation lasting more than 60 months prior to surgery are associated with an increased risk of recurrence postoperatively. Therefore, careful monitoring of these patients after discharge is essential for early detection and management of recurrences.